Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: Lost opportunities?

International Journal of Clinical Practice

Volumn 69, Issue 2, 2015, Pages 162-168

  Bodansky, D M S ^a   Allon, I R ^a   Apostolakis, S ^a   Lip, G Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; FIBRINOLYTIC AGENT; TICLOPIDINE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PALLIATIVE THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKING; TERMINAL CARE; TREATMENT DURATION; VERY ELDERLY; ANALOGS AND DERIVATIVES; ANGIOPLASTY; COMPLICATION; MIDDLE AGED; MORTALITY; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME; UTILIZATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANTICOAGULANTS; ASPIRIN; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84921830045     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12470     Document Type: Article

References (12)

1. Selvin E, Erlinger TP,. Prevalence of and risk factors for peripheral arterial disease in the United States: results From the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110 (6): 738-43.
2. National Institute for Health and Care Excellence. Lower limb peripheral arterial disease: diagnosis and management. London: National Institute for Health and Care Excellence, 2013.
3. Aronow W,. Peripheral arterial disease in the elderly. Clin Interv Aging 2007; 2 (4): 645-54.
4. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
5. Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH,. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2008; 8: 1-58.
6. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354 (18): 1879-88.
7. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348 (9038): 1329-39.
8. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ,. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. CHEST J 2012; 141 (Suppl. 2): 7S-47S.
9. Reaume KR, Regal RE, Dorsch MP,. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Ann Pharmacother 2008; 42 (4): 550-7.
10. Allemang MT, Rajani RR, Nelson PR, Hingorani A, Kashyap VS,. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures. Ann Vasc Surg 2013; 27 (1): 62-7.
11. Matas M, Domínguez González JM, Montull E,. Antiplatelet therapy in endovascular surgery: the RENDOVASC study. Ann Vasc Surg 2013; 27 (2): 168-77.
12. Bergs J, Hellings J, Cleemput I, et al. Systematic review and meta-analysis of the effect of the World Health Organisation surgiacl safety checklist on postoperative complcations. Br J Surg 2014; 101 (3): 150-8.